Latest Prostatype Genomics News & Updates

See the latest news and media coverage for Prostatype Genomics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Prostatype Genomics

Developer of prognostic prostate cancer genetic test

prostatypegenomics.com
Headquarters
Stockholm, Sweden
Founded year
2007
Company type
Public company
Number of employees
5–10
Industry
Advanced Medical Equipment & Technology

Last updated

Latest news about Prostatype Genomics

In short: Prostatype Genomics secured approximately 47.4 million SEK through a rights issue to fund its U.S. Medicare approval and commercialization.

Company announcements

Prostatype Genomics

Prostatype Genomics enters top-down underwriting for rights issue

The rights issue of SEK 47.4 million is now 91.3% covered through commitments and underwriting.

Unlock all announcements with a

Media coverage

Affärsvärlden

Five flags in Prostatype's new issue

The medical technology company Prostatype Genomics is conducting a rights issue that could bring the company 47 million kronor before costs. Emissionsguiden raises five flags.

FOX59

New multi-centre study in Spain shows very strong interim results for Prostatype®

STOCKHOLM, Oct. 25, 2023 /PRNewswire/ -- Prostatype Genomics is currently conducting a study of 160 patients together with seven leading Spanish hospitals and the Spanish...

Unlock all articles with a

Never miss news about Prostatype Genomics

Track Prostatype Genomics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.